Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.
McEwan P, Boyce R, Sanchez JJG, Sjöström CD, Stefansson B, Nolan S, Correa-Rotter R, Rossing P, Chertow GM, McMurray JJV, Wheeler DC, Heerspink HJL. McEwan P, et al. Nephrol Dial Transplant. 2023 May 4;38(5):1260-1270. doi: 10.1093/ndt/gfac280. Nephrol Dial Transplant. 2023. PMID: 36301617 Free PMC article. Clinical Trial.
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trial.
McEwan P, Morgan AR, Boyce R, Bergenheim K, Gause-Nilsson IAM, Bhatt DL, Leiter LA, Johansson PA, Mosenzon O, Cahn A, Wilding JPH. McEwan P, et al. Diabetes Obes Metab. 2021 Apr;23(4):1020-1029. doi: 10.1111/dom.14308. Epub 2021 Jan 25. Diabetes Obes Metab. 2021. PMID: 33368855 Free PMC article. Clinical Trial.
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.
Inker LA, Grams ME, Guðmundsdóttir H, McEwan P, Friedman R, Thompson A, Weiner DE, Willis K, Heerspink HJL; NKF-FDA Conference on Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases Advisory Group. Inker LA, et al. Among authors: mcewan p. Am J Kidney Dis. 2022 Oct;80(4):513-526. doi: 10.1053/j.ajkd.2022.03.011. Epub 2022 Aug 13. Am J Kidney Dis. 2022. PMID: 35970679
Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
McEwan P, Hafner M, Jha V, Correa-Rotter R, Chernin G, De Nicola L, Villanueva R, Wheeler DC, Barone S, Nolan S, Garcia Sanchez JJ. McEwan P, et al. J Med Econ. 2023 Jan-Dec;26(1):1407-1416. doi: 10.1080/13696998.2023.2264715. Epub 2023 Oct 31. J Med Econ. 2023. PMID: 37807895 Free article. Review.
281 results